EUVIMEDEUVIMED entdecken
Evaluationsstudie

Urge fecal incontinence: are intramural rectal injections of botulinum toxin a long-term treatment option?

Philippe Onana Ndong iD, Karine Baumstarck, Véronique Vitton

Techniques in Coloproctology · 2025

DOI: 10.1007/s10151-024-03050-x ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Techniques in Coloproctology, 2025. Verfasst von Philippe Onana Ndong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Service de Gastroentérologie, Hôpital L'Archet 2, Centre Hospitalier Universitaire de Nice, Nice, France. onana-ndong.p@chu-nice.fr. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Fecal Incontinence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Unsuccessful first-line conservative treatments for managing fecal incontinence (FI) lead to considering predominantly invasive options, posing challenges in terms of cost and patient acceptance of benefit/risk ratio. Recent data from a prospective randomized study have highlighted intramural rectal botulinum toxin (BoNT/A) injection as a promising minimally invasive alternative for urge FI, demonstrating efficacy at 3 months but lacking long-term evidence. This study aimed to evaluate the sustained efficacy and injection frequency of intramural rectal BoNT/A injection in the treatment of urge FI. METHODS: This retrospective monocentric study enrolled all patients who underwent intramural rectal BoNT/A injection for urge FI after failed conservative therapy or sacral neuromodulation (SNM). Injections were administered during sigmoidoscopy, delivering 200 U of BoNT/A at 10 circumferentially distributed sites. Treatment effectiveness was assessed using the Cleveland clinic incontinence score (CCS) and a visual analog scale (VAS) to measure the severity of discomfort related to episodes of fecal urgency, with reinjection performed upon symptom recurrence. RESULTS: In total, 41 patients (34 females) were included, with a median follow-up of 24.9 (range 3.2-70.3) months. Overall, 11 patients had previously failed sacral nerve stimulation. Significant reductions were observed in the CCS (median 11 versus 7, p = 0.001) and VAS symptoms (median 4, range 0-5 versus median 2, range 0-5, p = 0.001). In total, 22 patients (53%) experienced a reduction in the CCS by over 50%. The median interval between intramural rectal BoNT/A injections was 9.8 months (range 5.3-47.9 months). CONCLUSIONS: This study provides the first evidence of the sustained efficacy of intramural rectal BoNT/A injection for urge FI. Further investigations are warranted to refine patient selection and reinjection criteria, evaluate socioeconomic impacts, and compare rectal BoNT/A injection with other therapeutic modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AFecal IncontinenceHumansFemaleMaleRetrospective StudiesMiddle AgedTreatment OutcomeAgedAdultNeuromuscular AgentsRectumAdministration, RectalAged, 80 and overTime FactorsInjections

Stichwörter der Autor:innen

FIFecal incontinenceIntramural rectal botulinum toxin injectionLong term efficacyUrge fecal incontinence

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Service de Gastroentérologie, Hôpital L'Archet 2, Centre Hospitalier Universitaire de Nice, Nice, France. onana-ndong.p@chu-nice.fr.
  • Service d'Epidémiologie et Economie en Santé, Direction de la Recherche en Santé, AP-HM, Marseille, France.
  • Service de Gastroentérologie, Hôpital NORD, Assistance Publique Hôpitaux de Marseille; Aix-Marseille Université, Marseille, France.

ORCID-Profile: Philippe Onana Ndong

Zitieren

APA

Onana Ndong, P., Baumstarck, K., & Vitton, V. (2025). Urge fecal incontinence: are intramural rectal injections of botulinum toxin a long-term treatment option?. Techniques in Coloproctology. https://doi.org/10.1007/s10151-024-03050-x

Vancouver

Onana Ndong P, Baumstarck K, Vitton V. Urge fecal incontinence: are intramural rectal injections of botulinum toxin a long-term treatment option?. Techniques in Coloproctology. 2025. doi:10.1007/s10151-024-03050-x

BibTeX
@article{OnanaNdong2025,
  author = {Onana Ndong, Philippe and Baumstarck, Karine and Vitton, Véronique},
  title = {Urge fecal incontinence: are intramural rectal injections of botulinum toxin a long-term treatment option?},
  journal = {Techniques in Coloproctology},
  year = {2025},
  doi = {10.1007/s10151-024-03050-x}
}
Kostenlos starten →